StockNews.com initiated coverage on shares of BeiGene (NASDAQ:BGNE – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the stock. Several other ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which ...

BEIGENE (06160.HK) announced that according to US GAAP, the company expects to achieve positive operating income for the full ...

Despite a 15% drop in the SPDR S&P Biotech ETF, insider buying presents opportunities. Read why these small and mid-cap ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, is proud to join the global community in raising awareness about lymphoma on World Lymphoma Awareness Day (WLAD).

Dream Beyond: PAFF Unveils 2025 film Guide with Premieres, Award-Winning Selections, and Diverse Voices from 34 Countries Pan African Film & Arts Festival Pan African Film & Arts Festival +1 ...

BeiGene has said it intends to resubmit the drug for use by NHS Scotland. The recommendations come 10 months after Brukinsa was approved by the Medicines and Healthcare products Regulatory Agency ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ET Net News Agency, 24 January 2025] HANSOH PHARMA (03692) rose 3% to HK$17.8, breaking above the 50-D SMA of HK$17.727. It hits an intra-day high of HK$17.8, and an intra-day lo ...

ET Net News Agency, 22 January 2025] ASCENTAGE-B (06855) rose 10.1% to HK$42.6, breaking above the 100-D SMA of HK$40.948. It hits an intra-day high of HK$42.6, and an intra-day low of HK$39.5. The ...

Eli Lilly has been unable to secure an accelerated FDA approval for its anti-amyloid Alzheimer's disease therapy donanemab based on mid-stage clinical results, but says it remains on track to file ...